Myriad Genetics Inc. (MYGN) Reports In-Line Q2 EPS; Guides FY11 EPS Shy

January 27, 2011 4:10 PM

Myriad Genetics Inc. (NASDAQ: MYGN) reported Q2 EPS of $0.26, in-line with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found